dihydrotestosterone has been researched along with Urinary Bladder Neoplasms in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 8 (66.67) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Bai, X; Huang, W; Li, Y; Wang, H; Wang, X; Xiao, H; Yang, L | 1 |
Elahi Najafi, MA; Jiang, G; Miyamoto, H; Tatenuma, T; Teramoto, Y; Yasui, M | 1 |
Botto, H; Dreyfus, JF; Fiet, J; Ghoneim, TP; Giton, F; Lebret, T; Neuzillet, Y; Radulescu, C; Raynaud, JP | 1 |
Arai, Y; Azmahani, A; Fujishima, F; Hata, S; Ise, K; Konosu-Fukaya, S; McNamara, KM; Mitsuzuka, K; Nakamura, Y; Sasano, H; Shimada, K | 1 |
Fan, Y; Jarosek, SL; Konety, BR; Lawrentschuk, NL; Sathianathen, NJ | 1 |
Botto, H; Dreyfus, JF; Fiet, J; Ghoneim, T; Giton, F; Lebret, T; Meunier, ME; Neuzillet, Y; Radulescu, C; Raynaud, JP; Rouanne, M | 1 |
Ciołczyk-Wierzbicka, D; Dulińska-Litewka, J; Gil, D; Laidler, P; Lekka, M; Zarzycka, M | 1 |
El-Shishtawy, KA; Ide, H; Kashiwagi, E; Kawahara, T; Li, Y; Miyamoto, H; Reis, LO; Zheng, Y | 1 |
Izumi, K; Miyamoto, H; Yao, JL; Zheng, Y | 1 |
Chang, C; Hsu, JW; Izumi, K; Miyamoto, H; Zheng, Y | 1 |
Chen, F; Iwamoto, Y; Langenstroer, P; See, W; Zhang, G | 1 |
Kwan, PW; Leav, I; Merk, FB; Reid, LM; Russell, P | 1 |
1 trial(s) available for dihydrotestosterone and Urinary Bladder Neoplasms
Article | Year |
---|---|
Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study.
Topics: 5-alpha Reductase Inhibitors; Androgens; Dihydrotestosterone; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Urinary Bladder Neoplasms | 2018 |
11 other study(ies) available for dihydrotestosterone and Urinary Bladder Neoplasms
Article | Year |
---|---|
Androgen dihydrotestosterone promotes bladder cancer cell proliferation and invasion via EPPK1-mediated MAPK/JUP signalling.
Topics: Androgens; Animals; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Female; Humans; Male; Mice; Mice, Nude; Receptors, Androgen; Urinary Bladder Neoplasms | 2023 |
GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer.
Topics: Cell Line, Tumor; Cell Proliferation; Cisplatin; Dihydrotestosterone; Humans; Receptors, Androgen; Urinary Bladder Neoplasms | 2023 |
Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).
Topics: Aged; Androstenediol; Body Mass Index; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Estrone; Gas Chromatography-Mass Spectrometry; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Prospective Studies; Prostate; Prostatic Hyperplasia; Testosterone; Urinary Bladder Neoplasms | 2017 |
Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Aged; Aged, 80 and over; Androgens; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dihydrotestosterone; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Membrane Proteins; Middle Aged; Neoplasm Grading; Receptors, Androgen; RNA, Messenger; Urinary Bladder Neoplasms; Young Adult | 2017 |
Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).
Topics: Aged; Cystectomy; Dihydrotestosterone; Estradiol; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Urinary Bladder Neoplasms | 2019 |
Dihydrotestosterone increases the risk of bladder cancer in men.
Topics: Cells, Cultured; Dihydrotestosterone; Disease Progression; Epithelial-Mesenchymal Transition; Eukaryotic Initiation Factor-4E; Gene Expression; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Male; Molecular Targeted Therapy; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Risk; Sex Characteristics; Signal Transduction; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2019 |
Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth.
Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dihydrotestosterone; Down-Regulation; Flutamide; Humans; Interleukin-6; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Nitriles; Phenylthiohydantoin; Receptors, Androgen; RNA; Tosyl Compounds; Transcription, Genetic; Urinary Bladder Neoplasms | 2016 |
Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
Topics: Aged; Aged, 80 and over; Blotting, Western; Cell Proliferation; Dihydrotestosterone; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Staging; Phosphorylation; Receptor, ErbB-2; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured; Up-Regulation; Urinary Bladder Neoplasms | 2011 |
Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Animals; Cell Line; Cystectomy; Dihydrotestosterone; Down-Regulation; Female; Flutamide; Follow-Up Studies; Gene Expression Regulation, Enzymologic; Glucuronosyltransferase; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Orchiectomy; Receptors, Androgen; Reference Values; Signal Transduction; UDP-Glucuronosyltransferase 1A9; Urinary Bladder; Urinary Bladder Neoplasms | 2013 |
Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines.
Topics: Androgen Antagonists; Anilides; Autocrine Communication; BCG Vaccine; Carcinoma, Transitional Cell; Dihydrotestosterone; Dose-Response Relationship, Drug; Flutamide; Gene Expression; Genes, Reporter; Humans; Neoplasms, Hormone-Dependent; NF-kappa B; Nitriles; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tosyl Compounds; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vaccines, Attenuated | 2003 |
Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice.
Topics: Aged; Animals; Carcinoma, Papillary; Carcinoma, Transitional Cell; Castration; Cell Division; Dihydrotestosterone; Estradiol; Female; Humans; Karyotyping; Male; Mice; Mice, Nude; Microscopy, Electron; Neoplasm Transplantation; Transplantation, Heterologous; Urinary Bladder Neoplasms | 1984 |